RE:New high again today and big Volume!The combined impact of the two scenarios caused our Equal-Weighted Target Price (1 year) to increase to $6.02 from $4.44. However, until the full 2022 financials are released or the merger closes, we are maintaining a Buy rating and a one-year price target of $4.50.
https://eresearch.com/wp-content/uploads/2023/03/eR-DCM-2023_03_10_UR-MA-RRD-Can-FINAL.pdf